COMPASS Pathways plc

CMPS · Nasdaq · SIC 2834: Pharmaceutical Preparations
98
SEC Filings

Business Summary

EX-31.1 4 cmps-10xkxex311ceo302certi.htm EX-31.1 Document Exhibit 31.1 CERTIFICATION PURSUANT TO RULES 13a-14(a)AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION302 OF THE SARBANES-OXLEY ACT OF 2002 I, Kabir Nath, certify that 1. I have reviewed this Annual Report on Form10-K of COMPASS Pathways plc (the registrant) 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to mak...

Next Earnings

Q2 FY2026 — expected 2026-07-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCMPSdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPSdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPSdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPSdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001816590-26-000020EDGAR133K words
2025-02-272024-12-310001628280-25-008412EDGAR—
2024-02-292023-12-310001628280-24-007787EDGAR—
2023-02-282022-12-310001628280-23-005356EDGAR—
2022-02-242021-12-310001628280-22-003651EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001816590-25-000150EDGAR82K words
2025-07-312025-06-300001816590-25-000102EDGAR—
2025-05-082025-03-310001628280-25-023426EDGAR—
2024-10-312024-09-300001628280-24-044398EDGAR—
2024-08-012024-06-300001628280-24-033853EDGAR—
2024-05-082024-03-310001628280-24-021351EDGAR—
2023-11-022023-09-300001628280-23-036170EDGAR—
2023-08-032023-06-300001628280-23-026985EDGAR—
2023-05-112023-03-310001628280-23-017390EDGAR—
2022-11-032022-09-300001816590-22-000115EDGAR—
2022-08-042022-06-300001628280-22-020847EDGAR—
2022-05-102022-03-310001628280-22-013443EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001816590-26-000021EDGAR3K words
2026-02-190001628280-26-009501EDGAR—
2026-02-170001816590-26-000007EDGAR—
2026-01-070001816590-26-000004EDGAR—
2025-11-040001816590-25-000149EDGAR—
2025-10-290001816590-25-000141EDGAR—
2025-07-310001816590-25-000103EDGAR—
2025-07-290001816590-25-000094EDGAR—
2025-06-230001816590-25-000085EDGAR—
2025-06-130001816590-25-000067EDGAR—

98 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001816590
TickerCMPS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 35d842d1b98b8789e2eb72466edf4315fb122d29295a069f3b38378b352b888d
parent: f3eb48f85fa7ec891fad4b7976bac9695d2d06ab872c1bf7423af3d0cf8b5e97
content hash: 00bc89d6d042407aaf42afd9eb8e32a943d0f5b47e82e72a74787fb6ac1b3619
signed: 2026-04-13T04:44:23.606Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf